Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $2.23 billion. The enterprise value is $1.95 billion.
Market Cap | 2.23B |
Enterprise Value | 1.95B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
Earnings Date | Aug 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
IOVA has 279.83 million shares outstanding. The number of shares has increased by 24.58% in one year.
Shares Outstanding | 279.83M |
Shares Change (YoY) | +24.58% |
Shares Change (QoQ) | +3.92% |
Owned by Insiders (%) | 0.54% |
Owned by Institutions (%) | 89.46% |
Float | 207.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1,169.89 |
Forward PS | 8.02 |
PB Ratio | 3.28 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,023.75 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.63, with a Debt / Equity ratio of 0.12.
Current Ratio | 4.63 |
Quick Ratio | 4.36 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.50% and return on invested capital (ROIC) is -61.15%.
Return on Equity (ROE) | -71.50% |
Return on Assets (ROA) | -55.20% |
Return on Capital (ROIC) | -61.15% |
Revenue Per Employee | $3,418 |
Profits Per Employee | -$807,259 |
Employee Count | 557 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | -4.89M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.05% in the last 52 weeks. The beta is 0.63, so IOVA's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | +2.05% |
50-Day Moving Average | 8.96 |
200-Day Moving Average | 9.12 |
Relative Strength Index (RSI) | 43.95 |
Average Volume (20 Days) | 7,288,394 |
Short Selling Information
The latest short interest is 56.42 million, so 20.16% of the outstanding shares have been sold short.
Short Interest | 56.42M |
Short Previous Month | 54.63M |
Short % of Shares Out | 20.16% |
Short % of Float | 27.21% |
Short Ratio (days to cover) | 6.97 |
Income Statement
In the last 12 months, IOVA had revenue of $1.90 million and -$449.64 million in losses. Loss per share was -$1.80.
Revenue | 1.90M |
Gross Profit | -16.11M |
Operating Income | -467.43M |
Pretax Income | -454.53M |
Net Income | -449.64M |
EBITDA | -417.19M |
EBIT | -454.53M |
Loss Per Share | -$1.80 |
Balance Sheet
The company has $362.63 million in cash and $84.37 million in debt, giving a net cash position of $278.26 million or $0.99 per share.
Cash & Cash Equivalents | 362.63M |
Total Debt | 84.37M |
Net Cash | 278.26M |
Net Cash Per Share | $0.99 |
Equity (Book Value) | 680.02M |
Book Value Per Share | 2.43 |
Working Capital | 302.32M |
Cash Flow
In the last 12 months, operating cash flow was -$384.28 million and capital expenditures -$20.80 million, giving a free cash flow of -$405.08 million.
Operating Cash Flow | -384.28M |
Capital Expenditures | -20.80M |
Free Cash Flow | -405.08M |
FCF Per Share | -$1.52 |
Margins
Gross margin is -846.22%, with operating and profit margins of -24,549.63% and -23,615.70%.
Gross Margin | -846.22% |
Operating Margin | -24,549.63% |
Pretax Margin | -23,872.37% |
Profit Margin | -23,615.70% |
EBITDA Margin | -21,911.40% |
EBIT Margin | -23,872.37% |
FCF Margin | -21,275.26% |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -24.58% |
Shareholder Yield | -24.58% |
Earnings Yield | -20.19% |
FCF Yield | -18.19% |
Analyst Forecast
The average price target for IOVA is $25.70, which is 222.86% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $25.70 |
Price Target Difference | 222.86% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 311.39% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
Last Split Date | Sep 26, 2013 |
Split Type | Reverse |
Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of 2.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.32 |
Piotroski F-Score | 1 |